Summary by Moomoo AI
On February 14, 2024, Bristol-Myers Squibb Company announced the pricing of a multi-tranche debt offering totaling $11.75 billion, with varying maturities ranging from 2026 to 2064. The offering includes Floating Rate Notes due 2026, and fixed-rate notes with maturities in 2026, 2027, 2029, 2031, 2034, 2044, 2054, and 2064, each with specified interest rates, reoffer prices, and yield to maturities. The Floating Rate Notes will bear interest at a rate reset quarterly based on Compounded SOFR plus a margin. The settlement date for the notes is scheduled for February 22, 2024. The issuer's ratings by Moody's and S&P are A2 (negative) and A (stable), respectively. The offering is made under a previously filed registration statement with the SEC, and the notes will be issued in a T+5 settlement cycle. The announcement...Show More